These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8587398)

  • 41. Endothelin receptors that modulate contraction of the rat fundus.
    Gray GA; Breu V; Clozel M
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S126-9. PubMed ID: 8587339
    [TBL] [Abstract][Full Text] [Related]  

  • 42. PD 142893, SB 209670, and BQ 788 selectively antagonize vascular endothelial versus vascular smooth muscle ET(B)-receptor activity in the rat.
    Schroeder RL; Keiser JA; Cheng XM; Haleen SJ
    J Cardiovasc Pharmacol; 1998 Dec; 32(6):935-43. PubMed ID: 9869499
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Regional differences in the density and subtype specificity of endothelin receptors in rabbit urinary tract.
    Latifpour J; Fukumoto Y; Weiss RM
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Nov; 352(5):459-68. PubMed ID: 8751073
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rat striatum contains pure population of ETB receptors.
    Tayag EC; Jeng AY; Savage P; Lehmann JC
    Eur J Pharmacol; 1996 Apr; 300(3):261-5. PubMed ID: 8739217
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Binding of the nonpeptide antagonist, SB 209670, to endothelin receptors on cultured neurons.
    Lysko PG; Webb CL; Feuerstein G
    Peptides; 1995; 16(7):1279-82. PubMed ID: 8545251
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The unusual binding properties of the endothelin receptor antagonist CGS 27830 distinguishes receptor/agonist interactions.
    Chin MH; Cioffi CL; Garay M; Neale RF; Shetty SS; DelGrande D; Mugrage B; Sills MA; Lipson KE
    J Pharmacol Exp Ther; 1996 Jan; 276(1):74-83. PubMed ID: 8558459
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Subtypes of endothelin receptors that mediate venous effects of endothelin-1 in anaesthetized rats.
    Palacios B; Lim SL; Pang CC
    Br J Pharmacol; 1997 Nov; 122(6):993-8. PubMed ID: 9401760
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacological properties of endothelin receptor subtypes mediating positive inotropic effects in rabbit heart.
    Kasai H; Takanashi M; Takasaki C; Endoh M
    Am J Physiol; 1994 Jun; 266(6 Pt 2):H2220-8. PubMed ID: 8023985
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788.
    Ishikawa K; Ihara M; Noguchi K; Mase T; Mino N; Saeki T; Fukuroda T; Fukami T; Ozaki S; Nagase T
    Proc Natl Acad Sci U S A; 1994 May; 91(11):4892-6. PubMed ID: 8197152
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of peptidase and cyclooxygenase inhibitors in the guinea-pig bronchial response to the synthetic endothelin ET(B) agonist IRL 1620 and antagonist BQ-788.
    Lazzeri N; Nieri P; Lenzi P; Ratti C; Breschi MC
    J Auton Pharmacol; 1999 Aug; 19(4):201-7. PubMed ID: 10589970
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Distribution and functional significance of the endothelin receptor subtypes in the rat adrenal gland.
    Belloni AS; Pacheco YG; Markowska A; Andreis PG; Meneghelli V; Malendowicz LK; Nussdorfer GG
    Cell Tissue Res; 1997 May; 288(2):345-52. PubMed ID: 9082970
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Receptor selectivity of endothelin antagonists and prevention of vasoconstriction and endothelin-induced sudden death.
    Raschack M; Unger L; Riechers H; Klinge D
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S397-9. PubMed ID: 8587425
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sarafotoxin S6c: an agonist which distinguishes between endothelin receptor subtypes.
    Williams DL; Jones KL; Pettibone DJ; Lis EV; Clineschmidt BV
    Biochem Biophys Res Commun; 1991 Mar; 175(2):556-61. PubMed ID: 1850245
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of endothelin receptors and endothelin-converting enzyme activity in the rabbit lung.
    Gratton JP; Maurice MC; D'Orléans-Juste P
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S88-90. PubMed ID: 8587477
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Endothelin alters the reactivity of vasa vasorum: mechanisms and implications for conduit vessel physiology and pathophysiology.
    Scotland R; Vallance P; Ahluwalia A
    Br J Pharmacol; 1999 Nov; 128(6):1229-34. PubMed ID: 10578136
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of ETB receptor subtypes using linear and truncated analogs of ET.
    Nambi P; Pullen M; Brooks DP; Gellai M
    Neuropeptides; 1995 Dec; 29(6):331-6. PubMed ID: 8837960
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evidence that endothelin-1 (ET-1) inhibits insulin-stimulated glucose uptake in rat adipocytes mainly through ETA receptors.
    Lee YC; Juan CC; Fang VS; Hsu YP; Lin SH; Kwok CF; Ho LT
    Metabolism; 1998 Dec; 47(12):1468-71. PubMed ID: 9867075
    [TBL] [Abstract][Full Text] [Related]  

  • 58. SB 209670, a rationally designed potent nonpeptide endothelin receptor antagonist.
    Ohlstein EH; Nambi P; Douglas SA; Edwards RM; Gellai M; Lago A; Leber JD; Cousins RD; Gao A; Frazee JS
    Proc Natl Acad Sci U S A; 1994 Aug; 91(17):8052-6. PubMed ID: 8058755
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Endothelin receptor in microvessels isolated from human meningiomas: quantification with radioluminography.
    Yamaga S; Tsutsumi K; Niwa M; Kitagawa N; Anda T; Himeno A; Khalid H; Taniyama K; Shibata S
    Cell Mol Neurobiol; 1995 Jun; 15(3):327-40. PubMed ID: 7553732
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Endothelin and structurally related analogs distinguish between endothelin receptor subtypes.
    Panek RL; Major TC; Hingorani GP; Doherty AM; Taylor DG; Rapundalo ST
    Biochem Biophys Res Commun; 1992 Mar; 183(2):566-71. PubMed ID: 1312833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.